Mayflower Financial Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $491K | Sell |
|
|||||
|
2025
Q2 | $629K | Sell |
|
|||||
|
2025
Q1 | $723K | Buy |
|
|||||
|
2024
Q4 | $596K | Sell |
|
|||||
|
2024
Q3 | $689K | Sell |
|
|||||
|
2024
Q2 | $1.37M | Buy |
|
|||||
|
2024
Q1 | $1.23M | Buy |
|
|||||
|
2023
Q4 | $1.2M | Sell |
|
|||||
|
2023
Q3 | $1.14M | Sell |
|
|||||
|
2023
Q2 | $1.3M | Buy |
|
|||||
|
2023
Q1 | $1.24M | Buy |
|
|||||
|
2022
Q4 | $1.17M | Sell |
|
|||||
|
2022
Q3 | $1.22M | Sell |
|
|||||
|
2022
Q2 | $1.14M | Buy |
|
|||||
|
2022
Q1 | $1.12M | Buy |
|
|||||
|
2021
Q4 | $664K | Buy |
|
|||||
|
2021
Q3 | $601K | Buy |
|
|||||
|
2021
Q2 | $602K | Sell |
|
|||||
|
2021
Q1 | $618K | Buy |
|